These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6082407)

  • 21. [Current trends in brachytherapy by the afterloading technic].
    Orban R; Schumann E
    Radiobiol Radiother (Berl); 1984; 25(2):185-92. PubMed ID: 6377383
    [No Abstract]   [Full Text] [Related]  

  • 22. [Increased localization of radioisotopes during regional hyperoxygenation].
    Finney JA
    Minerva Med; 1967 Dec; 58(99):4492. PubMed ID: 6082412
    [No Abstract]   [Full Text] [Related]  

  • 23. Tumor control probability for tumor therapy with beta radionuclide interstitial injection.
    Chen Y; Geng J; Tian J; He Y; Chen S
    Biomed Mater Eng; 2004; 14(3):333-5. PubMed ID: 15299245
    [No Abstract]   [Full Text] [Related]  

  • 24. [RADIOTHERAPY AND SURGICAL TREATMENT OF NEOPLASMS OF THE ORAL CAVITY AND THEIR METASTASES].
    RACUGNO V; MARROCU F
    Rass Med Sarda; 1963; 65():285-311. PubMed ID: 14060683
    [No Abstract]   [Full Text] [Related]  

  • 25. Combined radiation and surgical management of cancer.
    Watson TA
    J Can Assoc Radiol; 1966 Sep; 17(3):162-6. PubMed ID: 5334464
    [No Abstract]   [Full Text] [Related]  

  • 26. Systemic and locoregional dosimetry in receptor radionuclide therapy with peptides.
    Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):288-95. PubMed ID: 17043626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Symposium: general approaches in the management of neoplasms. Findings and general concepts on the radiotherapeutic management of cancer].
    Noriega Limón J
    Cir Cir; 1969; 37(3):196-206. PubMed ID: 5350884
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical aspects of local and regional tumor therapy with 188Re-RC-160.
    Bender H; Zamora PO; Rhodes BA; Guhlke S; Biersack HJ
    Anticancer Res; 1997; 17(3B):1705-12. PubMed ID: 9179223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Complications of combined treatment with preoperative irradiation of tumors of main localization: the surgical opinion].
    Privalov AV
    Vestn Khir Im I I Grek; 2003; 162(5):105-8. PubMed ID: 14768120
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacokinetics and dosimetry of 188 Re-pharmaceuticals.
    Ferro-Flores G; Arteaga de Murphy C
    Adv Drug Deliv Rev; 2008 Sep; 60(12):1389-401. PubMed ID: 18547675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer: special considerations in older patients.
    Hall SW
    Geriatrics; 1984 Jul; 39(7):74-5, 77-8. PubMed ID: 6735184
    [No Abstract]   [Full Text] [Related]  

  • 32. [Shifts in the surgical role in the treatment of malignant tumors].
    van Dongen JA
    Ned Tijdschr Geneeskd; 1980 Oct; 124(41):1713-7. PubMed ID: 7432559
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical picture and pathogenesis of combined radiation injuries].
    Vasilenko IIa
    Med Radiol (Mosk); 1984 Jul; 29(7):70-6. PubMed ID: 6379362
    [No Abstract]   [Full Text] [Related]  

  • 34. ["Current problems of surgical oncology in relation to radiotherapy" round table conversation and discussion].
    Strahlentherapie Sonderb; 1981; 76():37-8. PubMed ID: 7303121
    [No Abstract]   [Full Text] [Related]  

  • 35. Radioimmunodiagnosis and radioimmunotherapy, 1982.
    Sfakianakis GN; DeLand FH
    J Nucl Med; 1982 Sep; 23(9):840-50. PubMed ID: 6180154
    [No Abstract]   [Full Text] [Related]  

  • 36. Radiation biology and potential therapeutic applications of radionuclides.
    Hofer KG
    Bull Cancer; 1980; 67(3):343-53. PubMed ID: 7407434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time-dose-fractionation in radioimmunotherapy: implications for selecting radionuclides.
    Rao DV; Howell RW
    J Nucl Med; 1993 Oct; 34(10):1801-10. PubMed ID: 8410301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Milestones in regional cancer treatment major contributions and contributors--past and present.
    Stephens FO
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1629-30. PubMed ID: 9382492
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase I study of intravenous Lu-labeled CC49 murine monoclonal antibody in patients with advanced adenocarcinoma.
    Mulligan T; Carrasquillo JA; Chung Y; Milenic DE; Schlom J; Feuerstein I; Paik C; Perentesis P; Reynolds J; Curt G
    Clin Cancer Res; 1995 Dec; 1(12):1447-54. PubMed ID: 9815943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential for gene-targeted radiation therapy of cancers.
    Panyutin IG; Neumann RD
    Trends Biotechnol; 2005 Oct; 23(10):492-6. PubMed ID: 16125814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.